Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Alnylam Acquires Rights To VEGF Patents From Hybridon

Aug. 5, 2004

By Aaron Lorenzo

Elusys Raises $10.2M Via Series D Financing Round

Aug. 4, 2004

By Aaron Lorenzo

Elusys Raises $10.2M Via Series D Financing Round

Aug. 4, 2004

By Aaron Lorenzo

Though Not Approved, La Jolla's Riquent Begins Phase IV Study

Aug. 3, 2004

By Aaron Lorenzo

Though Not Approved, La Jolla's Riquent Begins Phase IV Study

Aug. 3, 2004

By Aaron Lorenzo

CV Therapeutics Gets Second Ranexa SPA For Angina, ACS

Aug. 2, 2004

By Aaron Lorenzo

CV Therapeutics Gets Second Ranexa SPA For Angina, ACS

Aug. 2, 2004

By Aaron Lorenzo

SGX Acquires First Clinical Drug: Troxatyl For Cancer

July 30, 2004

By Aaron Lorenzo

SGX Acquires First Clinical Drug: Troxatyl For Cancer

July 30, 2004

By Aaron Lorenzo

MannKind IPO Prices Within Range; Shares Close Higher

July 29, 2004

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 24, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.